Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tracks blood markers to catch Post-Surgery problems early

NCT ID NCT07509710

Knowledge-focused Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 1,500 adults who have had gastrointestinal surgery to see if changes in routine blood tests can help doctors detect complications earlier. By looking at how markers like white blood cell count and C-reactive protein change over time, researchers hope to create a tool that guides decisions on when to do further testing or start treatment. The goal is to reduce unnecessary procedures and improve recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could give doctors a clearer way to detect complications early after gastrointestinal surgery, potentially improving patient outcomes and reducing healthcare costs.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test a new drug or therapy, and the findings may not change current practice immediately.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,500 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Eligible procedures will include major elective or urgent GI surgery, under general anaesthesia, at higher risk of early post-operative complications, involving: * Upper GI tract (oesophagus, stomach, duodenum) * Hepato-pancreato-biliary surgery * Small bowel and colorectal surgery Surgical procedure under local anaesthesia, including soft tissues, proctological intervention, abdominal wall, hiatal repair, exploring laparotomy or adhesiolisis in absence of bowel resection will not be considered for inclusion.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Elective or urgent major GI surgery * Availability of postoperative clinical data and at least three postoperative measurements of inflammatory markers to allow identification of trajectory patterns Exclusion Criteria * Procedures without postoperative monitoring * Death within 24 hours of surgery * Absence of key postoperative clinical or laboratory data

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Oncologic disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Oncologic disease Urgent surgery

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.